These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3080463)

  • 61. Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
    Hedin L; Olsson B; Diczfalusy M; Flyg C; Petersson AS; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1993 Apr; 76(4):962-7. PubMed ID: 8473411
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Short-term treatment of short stature and subnormal growth rate with human growth hormone.
    Raiti S; Kaplan SL; Van Vliet G; Moore WV
    J Pediatr; 1987 Mar; 110(3):357-61. PubMed ID: 3546649
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predicting the response of growth hormone-deficient children to long term treatment with human growth hormone.
    Rudman D; Kutner MH; Goldsmith MA; Blackston RD
    J Clin Endocrinol Metab; 1979 Mar; 48(3):472-7. PubMed ID: 218997
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Growth hormone treatment in patients with neurosecretory dysfunction.
    Rochiccioli P; Dechaux E; Tauber MT; Pienkowski C; Tiberge M
    Horm Res; 1990; 33 Suppl 4():97-101. PubMed ID: 2245976
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nine months' subcutaneous therapy with synthetic growth hormone releasing factor in children with short stature.
    Hümmelink R; Rohwedder R; Sippell WG
    Acta Paediatr Scand Suppl; 1987; 331():48-52. PubMed ID: 2886000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency.
    Romshe CA; Sotos JF
    J Pediatr; 1980 Jan; 96(1):127-31. PubMed ID: 7350292
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Growth response to human growth hormone treatment in children with partial and total growth hormone deficiency.
    Wit JM; Faber JA; Van den Brande JL
    Acta Paediatr Scand; 1986 Sep; 75(5):767-73. PubMed ID: 3564945
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Greater efficiency of human growth hormone therapy in children below five years of age with growth hormone deficiency. A 5-year follow-up study.
    Josefsberg Z; Bauman B; Pertzelan A; Laron Z
    Horm Res; 1987; 27(3):126-33. PubMed ID: 3692443
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An attempt to assess the replacement dose of human growth hormone in the treatment of growth hormone deficient children.
    Hibi I; Tanaka T; Yano H; Umezawa S; Kagawa J; Tanae A; Ishikawa E
    Acta Paediatr Scand Suppl; 1987; 337():87-92. PubMed ID: 3324640
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A dose-response curve for human growth hormone.
    Frasier SD; Costin G; Lippe BM; Aceto T; Bunger PF
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1213-7. PubMed ID: 7298800
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Growth hormone assessment by radioreceptor and radioimmunoassay. Radioreceptor assay and radioimmunoassay comparisons.
    LaFranchi S; Hanna CE; Jelen B
    Am J Dis Child; 1984 Jan; 138(1):23-7. PubMed ID: 6537873
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modulation of IGF-I receptors by exogenous hGH treatment in constitutionally short children.
    Eshet R; Klinger B; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1993 Dec; 39(6):687-93. PubMed ID: 8287588
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature.
    Romshe CA; Zipf WB; Miser A; Miser J; Sotos JF; Newton WA
    J Pediatr; 1984 Feb; 104(2):177-81. PubMed ID: 6582246
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major.
    Werther GA; Matthews RN; Burger HG; Herington AC
    J Clin Endocrinol Metab; 1981 Oct; 53(4):806-9. PubMed ID: 7026588
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.
    Bozzola M; Zecca M; Locatelli F; Radetti G; Pagani S; Autelli M; Tatò L; Chatelain P
    J Endocrinol Invest; 1998 Dec; 21(11):765-70. PubMed ID: 9972677
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transient partial hGH deficiency in prepubertal children with delay of growth.
    Gourmelen M; Pham-Huu-Trung MT; Girard F
    Pediatr Res; 1979 Apr; 13(4 Pt 1):221-4. PubMed ID: 471580
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Factors attenuating growth promoting effect of growth hormone therapy for Turner's syndrome.
    Sato T; Miyamori C; Kajiwara S; Miyagawa K; Shimizu M
    Endocrinol Jpn; 1988 Oct; 35(5):725-31. PubMed ID: 3146501
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of growth hormone sleep release and responses to pharmacological tests.
    Garnier PE; Raynaud F; Job JC
    Horm Res; 1985; 22(1-2):12-6. PubMed ID: 3897014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.
    Kastrup KW; Christiansen JS; Andersen JK; Orskov H
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):148-52. PubMed ID: 6637329
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of growth hormone secretion after completion of therapy.
    Gökşen D; Coker M; Ozkayin N; Darcan S
    Pediatr Int; 2001 Apr; 43(2):137-40. PubMed ID: 11285064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.